BiVictriX Therapeutics Plc (BVX.L)
GBp 10.0
(17.65%)
GBp 10.0
(17.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -165 Thousand GBP | -9.27% |
| 2022 | -151 Thousand GBP | -228.26% |
| 2021 | -46 Thousand GBP | -4500.0% |
| 2020 | -1000.00 GBP | 0.0% |
| 2019 | - GBP | 0.0% |
| 2018 | - GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -90 Thousand GBP | -1.12% |
| 2023 Q2 | -76 Thousand GBP | 40.63% |
| 2023 FY | -165 Thousand GBP | -9.27% |
| 2023 Q4 | -89 Thousand GBP | -17.11% |
| 2022 FY | -151 Thousand GBP | -228.26% |
| 2022 Q2 | -23 Thousand GBP | 39.47% |
| 2022 Q4 | -128 Thousand GBP | -456.52% |
| 2021 FY | -46 Thousand GBP | -4500.0% |
| 2021 Q4 | -38 Thousand GBP | -375.0% |
| 2021 Q2 | -8000.00 GBP | -700.0% |
| 2020 FY | -1000.00 GBP | 0.0% |
| 2020 Q2 | - GBP | 0.0% |
| 2020 Q4 | -1000.00 GBP | 0.0% |
| 2019 FY | - GBP | 0.0% |
| 2018 FY | - GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|